Marker Therapeutics Inc (MRKR : NASDAQ)
Common Stock
Follow MRKR
MRKR
Marker Therapeutics Inc
Performance
1 Day
+54.71%
1 Week
+46.67%
1 Month
+13.79%
YTD
-2.22%
The Saturday TSX Wrap · free, every saturday morning. The week on the TSX, in five minutes.
Key Statistics
Market Cap
$13.82M
52W High
$2.46
52W Low
$0.82
P/E Ratio
-
50 Day MA
$1.06
200 Day MA
$1.32
Beta
1.62
Dividend Yield
-
Performance history
MRKR returns since 2026
Marker Therapeutics Inc has traded since Jun 2026 in our data. Its deepest fall was −50.7% (Jul 2026 to Nov 2026).
1 year / yr
—
3 years / yr
—
5 years / yr
—
10 years / yr
—
Calendar-year returns
- 2026*−2.2%
* Partial year (first year of data, or year to date).
$10,000 invested in MRKR
- 2026 (start of our data)$9,778
- All-time high in our data
- $2 on Jul 7, 2026 · now −21.4%
Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Jun 2026 to Nov 2026. Past returns do not predict future ones.
Awesome Portfolio™
Looking past MRKR? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/19/2026 | $1.02 | $1.68 | $0.98 | $1.32 | $1.32 | 35,585,430 |
| 11/18/2026 | $0.84 | $0.92 | $0.83 | $0.85 | $0.85 | 105,817 |
| 11/17/2026 | $0.87 | $0.90 | $0.81 | $0.84 | $0.84 | 203,051 |
| 11/16/2026 | $0.90 | $0.91 | $0.82 | $0.83 | $0.83 | 135,857 |
| 11/13/2026 | $0.92 | $0.93 | $0.87 | $0.87 | $0.87 | 76,100 |
| 11/12/2026 | $0.94 | $0.97 | $0.90 | $0.90 | $0.90 | 140,799 |
| 11/11/2026 | $0.95 | $0.98 | $0.94 | $0.95 | $0.95 | 28,388 |
| 11/10/2026 | $1.01 | $1.03 | $0.95 | $0.95 | $0.95 | 53,000 |
| 11/9/2026 | $0.93 | $1.05 | $0.87 | $0.99 | $0.99 | 231,449 |
| 11/6/2026 | $0.90 | $0.95 | $0.89 | $0.89 | $0.89 | 50,400 |
Analyst Price Targets
Based on 3 analysts covering MRKR · as of Oct 5, 2026
Wall Street analysts forecast MRKR stock price to rise 496.0% over the next 12 months.
Consensus
Strong Buy5.00 / 5.00
Avg. Target
US$7.87
+496.0% Upside
Current Price
US$1.32
Last close
Analyst Breakdown (3 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MRKR's historical volatility
30-Day Vol
164.2%
Annualized
90-Day Vol
110.0%
Annualized
Trend (90d)
-39.5%
Annualized drift
90d Mean
US$1.15
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$1.26 | US$0.71 – US$2.22 |
| 60 trading days | US$1.20 | US$0.54 – US$2.68 |
| 90 trading days | US$1.15 | US$0.43 – US$3.06 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Marker Therapeutics Inc
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States. The company's multi antigen recognizing (MAR)-T cell therapy technology is based on the selective expansion of non-engineered tumor-specific T cells that recognize tumor-associated antigens and kill tumor cells expressing those targets. It develops MT-601, which is in Phase 1 trials for the treatment of lymphoma and pancreatic cancer; and MT-401-OTS, which is in a Phase 1 trial for the treatment of acute myeloid leukemia and myelodysplastic syndromes. The company was formerly known as TapImmune, Inc. and changed its name to Marker Therapeutics, Inc. in October 2018. Marker Therapeutics, Inc. was founded in 1999 and is headquartered in Houston, Texas.
Financials
- Revenue (TTM)
- $3.55M
- EBITDA
- $-11.79M
- Profit Margin
- -245.51%
- ROE (TTM)
- -76.87%
- EPS (Diluted)
- -0.39
- Book Value
- 0.73
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Free newsletter
The Saturday TSX Wrap
The week on the TSX, in five minutes
- The biggest gainers and losers, and why they moved
- Sector and momentum moves at a glance
- The Canadian market stories you missed
Explore More
Common Questions About MRKR.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| SEAT | Vivid Seats Inc | $2.09 | +63.28% |
| ELOG | Eastern International Ltd. | $1.45 | +46.46% |
| BAER | Bridger Aerospace Group Holdings, Inc. Common Stock | $0.31 | +45.64% |
| ZKIN | ZK International Group Co Ltd | $1.65 | +32.00% |
| FLD | Fold Holdings, Inc. Class A Common Stock | $0.29 | +27.19% |
| FISN | Deep Fission, Inc. Common Stock | $3.41 | +25.83% |
| ZEO | Zeo Energy Corp. | $0.29 | +24.09% |
| GMM | Global Mofy AI Limited | $1.92 | +23.87% |
Free with a Wealth Awesome account
Keep analysing MRKR, free
- Every WA Score, ranking and table
- Insider track records and SEDI filings
- Earnings history and analyst targets for every stock
Email only, no password, no card. Already a member? Use the same button to sign in.